Traci Carman

ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ.

Skyline Management LLC (Skyline Management) is a venture capital firm founded in 1997 by John Gordon Freund. The firm is headquartered in Palo Alto, California.

Helomics Corp. provides cancer care development and treatment consulting services. Its products include chemoFx, biospeciFx, geneFx colon and geneFx lung. It also offers research and development services. The company was founded in 1995 and is headquartered in Pittsburgh, PA.

AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE.

TVM Capital Corp (TVM Capital) is a venture capital subsidary of TVM Capital GmbH founded in 1986. The firm is headquartered in Boston, Massachusetts.

Epilepsy Foundation provides welfare services. It offers therapies to stop seizures, wellness institute and legal issue services. The company was founded in 1967 and is headquartered in Landover, MD.

New Jersey State Bar Association operates as a not-for-profit organization. It educates the public to enhance awareness of the legal system. The company was founded in June 1899 and is headquartered in New Brunswick, NJ.

Founded in 2004, Granite Point Capital Management LP is a hedge fund manager located in Boston, Massachusetts.

BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart.

Part of Pfizer Inc., Pfizer Pharmaceuticals, Inc. is an American company that manufactures pharmaceutical products.

Kent Place School, Inc. operates as girl's day school. The school operates preschool, primary school, middle school and upper school. The school was founded in 1894 and is headquartered in Summit, NJ.

Implicit Bioscience Ltd. operates as a clinical-stage immunotherapy drug development company. It develops drugs that modulate the host immune response to disease. The firm develops small molecule dipeptide oglufanide disodium for community and hospital-acquired infections including those caused by bio-threat agents. The company was founded by Garry Llewellyn Redlich, Peter Ronald Andrews and Ian Hector Frazer and is headquartered in Woolloongabba, Australia.

Part of Pfizer Inc., Pfizer Japan, Inc. is a research and Japanese development pharmaceutical company founded in 1953. The company is based in Tokyo, Japan. The company's focus is on breakthroughs that greatly change patients' lives, contributing to the improvement of patients' health and life expectancy.

Engage Therapeutics, Inc. engages in the development of rescue therapy for uncontrolled epileptic seizures. The company was founded by Gregory T. Mayes III and Jouko Isojarvi in 2017 and is headquartered in Summit, NJ.

North Jersey Masters Track & Field Club operates as a national governing body for running. The private company is based in Ridgewood, NJ.

Tevard Biosciences, Inc. is a biotechnology company based in Cambridge, MA. Tevard Biosciences is focused on developing trna-based and other modulating therapies to cure a broad range of genetic diseases. The company is advancing the use of its novel suppressor trna, enhancer trna, and mrna amplifier platforms in neurological disorders, heart disease, and muscular dystrophies. The company was founded in 2017 by Warren Burt Lammert, Harvey F. Lodish, Daniel Fischer, and Jeffrey Coller. Daniel Fischer has been the CEO since 2017.

Receptor Holdings, Inc. operates as a biopharmaceutical company. It develops oral and inhaled cannabinoid medicines. The company was founded by Gregory F. Wesner, Andrea Leone-Bay, Traci A. Carman, and Arthur Rubinfeld in 2018 and is headquartered in Seattle, WA.

Antios Therapeutics, Inc. operates as a biopharmaceutical company devoted to developing therapies for viral diseases. The company was founded by Abel De La Rosa, Doug Mayers and Idean Marvasty on October 30, 2018 and is headquartered in Atlanta, GA.

BYOMass, Inc. provides investment holding services. The company is headquartered in Sudbury, MA.

Silver Spike Capital LLC provides investment services. The company was founded by Scott Gordon in 2019 and is headquartered in New York. NY.

Silver Spike Sponsor III LLC provides investment services. The private company is based in New York, NY.

Spoke Sciences, Inc. is an ingredient technology company that develops innovative approaches to provide better, safer, and more reliable functional ingredients to foods, beverages, and cosmetics. The company is based in Bainbridge Island, WA. The company's team of pharmaceutical and consumer products industry veterans bridges the best ideas from pharma and applies them in novel ways to improved consumer goods. Spoke Sciences has been developing a portfolio of groundbreaking technology to solve solubility needs and is advancing patented technologies developed in pharma and applying those to innovative consumer products. Gregory F Wesner has been the CEO of the company since 2021.

Regel Therapeutics Inc. develops a proprietary technology platform related to gene therapy. The company is based in Cambridge, MA. The company was founded in 2020 by Navneet Matharu, Jordane Dimidschstein, Steven B. Ruchefsky, Michael Jasulavic, Orrin Devinsky. Steven B. Ruchefsky has been the CEO since 2020.

SCRIPT Biosciences, Inc. develops a genome editing platform. The American company was founded in 2020. Anil Namboodiripad has been the CEO of the company since 2021.

Reunion Neuroscience, Inc. operates drug discovery and development business. Its novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company was founded on October 1, 2020 and is headquartered in Toronto, Canada.

Phifund Managers, LLC (Phifund Managers) is a venture capital firm founded in 2021.The firm is headquartered in New York.

HitchBio, Inc. develops solutions based on red blood cell transfusion.